Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Korean researchers discover novel antimitotic agents

Feb. 24, 2010

Bromotetrandrine well tolerated and slowly cleared in healthy volunteers

Feb. 24, 2010

Lilly, Merck and Pfizer form Asian Cancer Research Group

Feb. 23, 2010

Novel HSP90 inhibitors identified by sanofi-aventis

Feb. 23, 2010

Dual PI3K/mTOR inhibitor with potent preclinical antitumor activity enters phase I trial

Feb. 23, 2010

Genentech identifies novel Janus kinase inhibitors

Feb. 22, 2010

Novel IGF-1R inhibitors disclosed by IRM

Feb. 22, 2010

Phase I data show safety of proapoptotic receptor agonist antibody in advanced malignancies

Feb. 22, 2010

FDA grants orphan drug status to EntreMed's ENMD-2076 for acute myeloid leukemia

Feb. 19, 2010

FDA grants priority review to Novartis' Tasigna for newly diagnosed Ph+CML

Feb. 19, 2010

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 7, 2026.
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
In the clinic for July 6, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Arcus, Genentech, Merck, Myriad, Otsuka, Partner, Revolution, Treos.